Semaglutide Cardiovascular Outcomes: SUSTAIN and SELECT Trials

Research Guide | 2026-05-01 | 7.3 min read

Deep dive into semaglutide cardiovascular outcomes: SUSTAIN-6, PIONEER-6, SELECT trial results, MACE reduction, and cardiovascular safety in obesity research.

Deep dive into semaglutide cardiovascular outcomes: SUSTAIN-6, PIONEER-6, SELECT trial results, MACE reduction, and cardiovascular safety in obesity research.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.

Research peptide catalogSupplier checklistMore peptide guides